Direct injection of calcitriol or its analog into hyperplastic parathyroid glands induces apoptosis of parathyroid cells

K. Shiizaki, S. Negi, I. Hatamura, K. Tatsuta, M. Shibata, S. Shimada, T. Sakaguchi, T. Akizawa

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Hyperplasia of the parathyroid gland (PTG) is associated not only with excessive secretion of parathyroid hormone (PTH) but also with changes in the parathyroid cell (PTC) characteristics (i.e. hyperproliferative activity, and low contents of vitamin D and calcium-sensing receptors). Control of PTG hyperplasia is most important in the management of secondary hyperparathyroidism, but the advanced stage of hyperplasia is considered irreversible. In the present study, dialysis patients with PTG hyperplasia underwent direct injection of calcitriol or maxacalcitol (OCT) into the PTG. Ultrasonography showed that this treatment had significantly reduced PTG volume and tissue analysis using the terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) method and DNA electrophoresis indicated that cellular apoptosis had been induced. The mechanism of apoptosis was evaluated in detail in uremic rats fed a high-phosphate diet. OCT or its vehicle was directly injected into the rats' PTGs. In the PTGs treated by OCT, there was a significantly increased number of TUNEL-positive PTCs and DNA electrophoresis revealed the characteristic ladder pattern of DNA fragmentation, both findings indicative of apoptosis. There was also a significant upregulation of both vitamin D and Ca-sensing receptors in the PTCs and a clear shift of the Ca-PTH response curve to the left and downward. None of these findings was observed in the PTGs treated by vehicle. This novel treatment is successful in causing regression of PTG hyperplasia. Thus, it is expected to significantly reduce the PTH level and ameliorate the abnormal bone turnover and mineral metabolism.

Original languageEnglish (US)
JournalKidney International
Volume70
Issue numberSUPPL. 102
DOIs
StatePublished - Jul 2006

Fingerprint

Parathyroid Glands
Calcitriol
Hyperplasia
Apoptosis
Injections
Parathyroid Hormone
Calcium-Sensing Receptors
Factor IX
Vitamin D
Electrophoresis
Secondary Hyperparathyroidism
DNA Nucleotidylexotransferase
Bone Remodeling
DNA
DNA Fragmentation
Transferases
Minerals
Dialysis
Ultrasonography
Up-Regulation

Keywords

  • DNA fragmentation
  • End-stage renal disease (ESRD)
  • Interventional ultrasonography
  • Parathyroid hyperplasia
  • Secondary hyperparathyroidism
  • Vitamin D

ASJC Scopus subject areas

  • Nephrology

Cite this

Shiizaki, K., Negi, S., Hatamura, I., Tatsuta, K., Shibata, M., Shimada, S., ... Akizawa, T. (2006). Direct injection of calcitriol or its analog into hyperplastic parathyroid glands induces apoptosis of parathyroid cells. Kidney International, 70(SUPPL. 102). https://doi.org/10.1038/sj.ki.5001596

Direct injection of calcitriol or its analog into hyperplastic parathyroid glands induces apoptosis of parathyroid cells. / Shiizaki, K.; Negi, S.; Hatamura, I.; Tatsuta, K.; Shibata, M.; Shimada, S.; Sakaguchi, T.; Akizawa, T.

In: Kidney International, Vol. 70, No. SUPPL. 102, 07.2006.

Research output: Contribution to journalArticle

Shiizaki, K, Negi, S, Hatamura, I, Tatsuta, K, Shibata, M, Shimada, S, Sakaguchi, T & Akizawa, T 2006, 'Direct injection of calcitriol or its analog into hyperplastic parathyroid glands induces apoptosis of parathyroid cells', Kidney International, vol. 70, no. SUPPL. 102. https://doi.org/10.1038/sj.ki.5001596
Shiizaki, K. ; Negi, S. ; Hatamura, I. ; Tatsuta, K. ; Shibata, M. ; Shimada, S. ; Sakaguchi, T. ; Akizawa, T. / Direct injection of calcitriol or its analog into hyperplastic parathyroid glands induces apoptosis of parathyroid cells. In: Kidney International. 2006 ; Vol. 70, No. SUPPL. 102.
@article{4342f29f02f54995af17d810df67dc9b,
title = "Direct injection of calcitriol or its analog into hyperplastic parathyroid glands induces apoptosis of parathyroid cells",
abstract = "Hyperplasia of the parathyroid gland (PTG) is associated not only with excessive secretion of parathyroid hormone (PTH) but also with changes in the parathyroid cell (PTC) characteristics (i.e. hyperproliferative activity, and low contents of vitamin D and calcium-sensing receptors). Control of PTG hyperplasia is most important in the management of secondary hyperparathyroidism, but the advanced stage of hyperplasia is considered irreversible. In the present study, dialysis patients with PTG hyperplasia underwent direct injection of calcitriol or maxacalcitol (OCT) into the PTG. Ultrasonography showed that this treatment had significantly reduced PTG volume and tissue analysis using the terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) method and DNA electrophoresis indicated that cellular apoptosis had been induced. The mechanism of apoptosis was evaluated in detail in uremic rats fed a high-phosphate diet. OCT or its vehicle was directly injected into the rats' PTGs. In the PTGs treated by OCT, there was a significantly increased number of TUNEL-positive PTCs and DNA electrophoresis revealed the characteristic ladder pattern of DNA fragmentation, both findings indicative of apoptosis. There was also a significant upregulation of both vitamin D and Ca-sensing receptors in the PTCs and a clear shift of the Ca-PTH response curve to the left and downward. None of these findings was observed in the PTGs treated by vehicle. This novel treatment is successful in causing regression of PTG hyperplasia. Thus, it is expected to significantly reduce the PTH level and ameliorate the abnormal bone turnover and mineral metabolism.",
keywords = "DNA fragmentation, End-stage renal disease (ESRD), Interventional ultrasonography, Parathyroid hyperplasia, Secondary hyperparathyroidism, Vitamin D",
author = "K. Shiizaki and S. Negi and I. Hatamura and K. Tatsuta and M. Shibata and S. Shimada and T. Sakaguchi and T. Akizawa",
year = "2006",
month = "7",
doi = "10.1038/sj.ki.5001596",
language = "English (US)",
volume = "70",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "SUPPL. 102",

}

TY - JOUR

T1 - Direct injection of calcitriol or its analog into hyperplastic parathyroid glands induces apoptosis of parathyroid cells

AU - Shiizaki, K.

AU - Negi, S.

AU - Hatamura, I.

AU - Tatsuta, K.

AU - Shibata, M.

AU - Shimada, S.

AU - Sakaguchi, T.

AU - Akizawa, T.

PY - 2006/7

Y1 - 2006/7

N2 - Hyperplasia of the parathyroid gland (PTG) is associated not only with excessive secretion of parathyroid hormone (PTH) but also with changes in the parathyroid cell (PTC) characteristics (i.e. hyperproliferative activity, and low contents of vitamin D and calcium-sensing receptors). Control of PTG hyperplasia is most important in the management of secondary hyperparathyroidism, but the advanced stage of hyperplasia is considered irreversible. In the present study, dialysis patients with PTG hyperplasia underwent direct injection of calcitriol or maxacalcitol (OCT) into the PTG. Ultrasonography showed that this treatment had significantly reduced PTG volume and tissue analysis using the terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) method and DNA electrophoresis indicated that cellular apoptosis had been induced. The mechanism of apoptosis was evaluated in detail in uremic rats fed a high-phosphate diet. OCT or its vehicle was directly injected into the rats' PTGs. In the PTGs treated by OCT, there was a significantly increased number of TUNEL-positive PTCs and DNA electrophoresis revealed the characteristic ladder pattern of DNA fragmentation, both findings indicative of apoptosis. There was also a significant upregulation of both vitamin D and Ca-sensing receptors in the PTCs and a clear shift of the Ca-PTH response curve to the left and downward. None of these findings was observed in the PTGs treated by vehicle. This novel treatment is successful in causing regression of PTG hyperplasia. Thus, it is expected to significantly reduce the PTH level and ameliorate the abnormal bone turnover and mineral metabolism.

AB - Hyperplasia of the parathyroid gland (PTG) is associated not only with excessive secretion of parathyroid hormone (PTH) but also with changes in the parathyroid cell (PTC) characteristics (i.e. hyperproliferative activity, and low contents of vitamin D and calcium-sensing receptors). Control of PTG hyperplasia is most important in the management of secondary hyperparathyroidism, but the advanced stage of hyperplasia is considered irreversible. In the present study, dialysis patients with PTG hyperplasia underwent direct injection of calcitriol or maxacalcitol (OCT) into the PTG. Ultrasonography showed that this treatment had significantly reduced PTG volume and tissue analysis using the terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) method and DNA electrophoresis indicated that cellular apoptosis had been induced. The mechanism of apoptosis was evaluated in detail in uremic rats fed a high-phosphate diet. OCT or its vehicle was directly injected into the rats' PTGs. In the PTGs treated by OCT, there was a significantly increased number of TUNEL-positive PTCs and DNA electrophoresis revealed the characteristic ladder pattern of DNA fragmentation, both findings indicative of apoptosis. There was also a significant upregulation of both vitamin D and Ca-sensing receptors in the PTCs and a clear shift of the Ca-PTH response curve to the left and downward. None of these findings was observed in the PTGs treated by vehicle. This novel treatment is successful in causing regression of PTG hyperplasia. Thus, it is expected to significantly reduce the PTH level and ameliorate the abnormal bone turnover and mineral metabolism.

KW - DNA fragmentation

KW - End-stage renal disease (ESRD)

KW - Interventional ultrasonography

KW - Parathyroid hyperplasia

KW - Secondary hyperparathyroidism

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=33745635340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745635340&partnerID=8YFLogxK

U2 - 10.1038/sj.ki.5001596

DO - 10.1038/sj.ki.5001596

M3 - Article

C2 - 16810304

AN - SCOPUS:33745635340

VL - 70

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - SUPPL. 102

ER -